Currently predicting for Thu, 2 May 2024

Trading levels for APTO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.25 3.31 %
R2 1.23 2.04 %
R1 1.23 1.26 %
Current price: 1.21
Support S1 1.19 -1.26 %
S2 1.19 -2.04 %
S3 1.17 -3.31 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.50 23.97 %
R2 1.44 19.01 %
R1 1.22 0.83 %
Current price 1.21
Support S1 1.20 -0.83%
S2 1.16 -4.13%
S3 0 .

APTO Predictions History

5 years ago
Andrew.P.83148 predicted that APTO for 2018-07-02 is going $4.53 (14.97%)

Rank:

5 years ago
Draymond.Green.82429 predicted that APTO for 2018-06-21 is going $4.20 (0.00%)

Rank:

5 years ago
JS predicted that APTO for 2018-06-21 is going $4.32 (2.86%)

5 years ago
JS predicted that APTO for 2018-06-20 is going $4.40 (4.76%)

6 years ago
JS predicted that APTO for 2018-01-18 is going $2.81 (0.36%)

6 years ago
JS predicted that APTO for 2017-11-17 is going $1.70 (-11.46%)

6 years ago
bbullish2 predicted that APTO for 2017-06-15 is going $1.49 (17.32%)

6 years ago
Seth.Alexander.8200 predicted that APTO for 2017-06-14 is going $1.62 (3.85%)

Rank:

6 years ago
JS predicted that APTO for 2017-05-08 is going $1.21 (-5.47%)

6 years ago
Martin.Drouin.6635 predicted that APTO for 2017-05-08 is going $1.80 (44.00%)

Rank:
Click to get the best stock tips daily for free!

About Aptose Biosciences

Aptose Biosciences Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Ph... APTO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT